Zydus receives USFDA nod for Losartan Potassium tablets

New Delhi, Apr 20 (UNI) Pharma major Cadila Healthcare Ltd today said it has received USFDA approval for its anti-hypertensive tablets, Losartan Potassium.

The tablets will be available in the strengths of 25 mg, 50 mg and 100 mg.

The group has recieved 23 approvals, since the commencement of the filing process in the financial year 2003-04.

The group is currently marketing nine generics through its US-based subsidiary Zydus Pharmaceuticals Inc.

UNI